-
Perceived Impact and Actionability of Barriers to Drug Repurposing: Insights From a Multistakeholder Policy Survey
Sep 9, 2025, 16:22 PM -
Evolving Payer Preferences for Health Economic Information and Communication in the US
Sep 9, 2025, 16:22 PM -
Factors Associated With Positive Cost-Effectiveness Judgments in HIRA Drug Reimbursement Decisions: An 8-year Retrospective Review
Sep 9, 2025, 16:22 PM -
Qualitative Literature Review Exploring the Patient Experience of Shortness of Breath in COPD and Asthma
Sep 9, 2025, 16:22 PM -
Comparative Assessment of Health-Related Quality of Life Among the Lebanese Population Pre- and Post-COVID-19 Pandemic
Sep 9, 2025, 16:22 PM -
ShinyMMD: An Open-Source Shiny Web Application for a Computer Simulation Model for Type 2 Diabetes and Its Complications
Sep 9, 2025, 16:22 PM -
A Systematic Literature Review of Economic Evaluation Studies for Schizophrenia
Sep 9, 2025, 16:22 PM -
Embracing the Long-Term in Disruptive Health Innovations: A Strategic Necessity or a Necessary Evil? Cost Utility of Langerhans Islet Grafting in Unstable Type 1 Diabetes
Sep 9, 2025, 16:22 PM -
Analysis of Factors Behind Differences Between Official Drug Pricing and Cost-Effectiveness Evaluation in Japan and Policy Implications
Sep 9, 2025, 16:22 PM -
Personalized Treatment Optimization Using Reinforcement Learning on Real-World Data (RWD)
Sep 9, 2025, 16:22 PM -
The Impact of Socioeconomic and Clinical Factors on Mental Healthcare Expenditure: Enabling Quality Managed Care Decisions
Sep 9, 2025, 16:22 PM -
Exploring the Impact of Socioeconomic Factors on COVID-19 Vaccine Hesitancy in India: What Can We Learn From the COVID-19 Pandemic? A Scoping Review
Sep 9, 2025, 16:22 PM -
An Irish Retrospective Analysis of Oncology Reimbursement Applications Considered by HSE Drugs Group 2022-2024
Sep 9, 2025, 16:22 PM -
Societal and Economic Burden of Obesity in Bulgaria
Sep 9, 2025, 16:22 PM -
A Review of Utility Data Used in Health Technology Assessments From the Perspective of a Health Technology Assessment Body
Sep 9, 2025, 16:22 PM -
Can an Ensemble Machine-Learning Approach Outperform Traditional Models While Enhancing Accuracy, Fairness, and Interpretability in Clinical Risk Prediction?
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Modeling Challenges and Trends in the Neoadjuvant and Perioperative Settings: A Review of NICE Oncology Submissions
Sep 9, 2025, 16:22 PM -
Correlation of Intermediate Clinical Endpoints (ICES) For Overall Survival (OS) In Localized or Locally Advanced Prostate Cancer (LPC/LAPC): Analysis of Individual Real-World Data (RWD)
Sep 9, 2025, 16:22 PM -
Bridging the Survival Extrapolation Gap in Health Economic Models: A Case Study on Spline-Based Survival Analysis Using ML-NMR to Address Complex Hazard Function
Sep 9, 2025, 16:22 PM -
Missed Opportunities in the Diagnosis and Management of Stage 3 Chronic Kidney Disease in General Practice: Insights From the Italian THIN Database
Sep 9, 2025, 16:22 PM
